@divakarssathya tweets related to: Glivec, Innovation, Improvements, Products, Patents

The landmark judgement of the Supreme Court striking down the application of Novartis AG for the grant of patent on an anti-cancer medicine, Glivec, has been hailed as an important step in putting the interests of consumers ahead of the profits of the big pharmaceutical firms. The ruling will allow generic firms to market their version of the medicine at a price 15 times lower than that charged by Novartis.
divakar s natarajan Twitter

Glivec and the question of innovation http://www.livemint.com/Opinion/ZdNAcYqLytenU1TRtdJlsN/Glivec-and-the-question-of-innovation.html Incremental improvements of existing products to secure patents are a menace to innovation.

divakar s natarajan Twitter

See what's Trending Now for @divakarssathya

See All Trending »
divakar s natarajan

Follow @divakarssathya on Twitter